Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2012 | 1 |
2013 | 1 |
2014 | 2 |
2016 | 2 |
2017 | 1 |
2018 | 2 |
2019 | 1 |
2021 | 1 |
2022 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
15 results
Results by year
Page 1
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.
N Engl J Med. 2019.
PMID: 30415628
Clinical Trial.
Homologous and Heterologous Covid-19 Booster Vaccinations.
N Engl J Med. 2022 Mar 17;386(11):1046-1057. doi: 10.1056/NEJMoa2116414. Epub 2022 Jan 26.
N Engl J Med. 2022.
PMID: 35081293
Free PMC article.
Clinical Trial.
Human genome meeting 2016 : Houston, TX, USA. 28 February - 2 March 2016.
Hum Genomics. 2016 May 26;10 Suppl 1(Suppl 1):12. doi: 10.1186/s40246-016-0063-5.
Hum Genomics. 2016.
PMID: 27294413
Free PMC article.
Ding, N. Veeraraghavan, Y. Yang, E. Boerwinkle, A. L. Beaudet, C. M. Eng, D. M. Muzny, R. A. Gibbs O56 A diploid personal human genome model for better genomes from diverse sequence data K. ...Sherry P38 Computational assessment of drug induced hepatotoxicity throug …
Ding, N. Veeraraghavan, Y. Yang, E. Boerwinkle, A. L. Beaudet, C. M. Eng, D. M. Muzny, R. A. Gibbs O56 A diploid personal huma …
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024.
N Engl J Med. 2022.
PMID: 35939578
Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025.
N Engl J Med. 2022.
PMID: 36069871
Clinical Trial.
Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial.
Ann Intern Med. 2023 May;176(5):667-675. doi: 10.7326/M22-3305. Epub 2023 Apr 18.
Ann Intern Med. 2023.
PMID: 37068273
Free PMC article.
Clinical Trial.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28.
Circulation. 2021.
PMID: 34710343
Free article.
Clinical Trial.
Nuclear Modification Factor of Neutral Pions in the Forward and Backward Regions in p-Pb Collisions.
Phys Rev Lett. 2023 Jul 28;131(4):042302. doi: 10.1103/PhysRevLett.131.042302.
Phys Rev Lett. 2023.
PMID: 37566846
Free article.
The pi^{0} production cross section is measured differentially in transverse momentum (p_{T}) for 1.5c.m.}) regions 2.5<eta_{c.m.}<3.5 (forward) and -4.0<eta_{c.m.} …
The pi^{0} production cross section is measured differentially in transverse momentum (p_{T}) for 1.5
Precision measurement of the mass and lifetime of the Ξ(b)(0) baryon.
Phys Rev Lett. 2014 Jul 18;113(3):032001. doi: 10.1103/PhysRevLett.113.032001. Epub 2014 Jul 15.
Phys Rev Lett. 2014.
PMID: 25083633
Free article.
From this sample, the first measurement of the xi(b)(0) baryon lifetime is made, relative to that of the lambda(b)(0) baryon. The mass differences M(xi(b)(0))-M(lambda(b)(0)) and M(xi(c)(+))-M(lambda(c)(+)) are also measured with precision more than 4 times better t …
From this sample, the first measurement of the xi(b)(0) baryon lifetime is made, relative to that of the lambda(b)(0) baryon. The mass diffe …
Measurements of B(c)+ production and mass with the B(c)+ → J/ψπ+ decay.
Phys Rev Lett. 2012 Dec 7;109(23):232001. doi: 10.1103/PhysRevLett.109.232001. Epub 2012 Dec 5.
Phys Rev Lett. 2012.
PMID: 23368183
Free article.
The B(c)(+) mass is directly measured to be 6273.71.3(stat)1.6(syst) MeV/c(2), and the measured mass difference with respect to the B(+) meson is M(B(c)(+))-M(B(+))=994.61.3(stat)0.6(syst) MeV/c(2)....
The B(c)(+) mass is directly measured to be 6273.71.3(stat)1.6(syst) MeV/c(2), and the measured mass difference with respect to the B(+) mes …
Cite